GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (LTS:0HF3) » Definitions » Cyclically Adjusted Revenue per Share

Cencora (LTS:0HF3) Cyclically Adjusted Revenue per Share : $1,034.91 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cencora Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cencora's adjusted revenue per share for the three months ended in Mar. 2024 was $340.070. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1,034.91 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Cencora's average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 15.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cencora was 16.90% per year. The lowest was 13.00% per year. And the median was 15.10% per year.

As of today (2024-05-23), Cencora's current stock price is $216.74. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $1,034.91. Cencora's Cyclically Adjusted PS Ratio of today is 0.21.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.39. The lowest was 0.14. And the median was 0.19.


Cencora Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Cencora's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Cyclically Adjusted Revenue per Share Chart

Cencora Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 565.28 682.51 763.03 881.47 992.56

Cencora Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 927.98 963.19 992.56 999.63 1,034.91

Competitive Comparison of Cencora's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.



Cencora Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cencora's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=340.07/131.7762*131.7762
=340.070

Current CPI (Mar. 2024) = 131.7762.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 134.446 100.560 176.182
201409 134.406 100.428 176.361
201412 153.054 99.070 203.583
201503 148.333 99.621 196.211
201506 142.500 100.684 186.506
201509 167.252 100.392 219.539
201512 161.915 99.792 213.809
201603 158.343 100.470 207.681
201606 164.063 101.688 212.607
201609 165.540 101.861 214.157
201612 171.950 101.863 222.446
201703 167.920 102.862 215.121
201706 174.456 103.349 222.442
201709 176.762 104.136 223.680
201712 183.253 104.011 232.171
201803 184.585 105.290 231.019
201806 195.426 106.317 242.224
201809 199.110 106.507 246.350
201812 212.145 105.998 263.738
201903 203.797 107.251 250.401
201906 214.241 108.070 261.238
201909 213.353 108.329 259.531
201912 230.655 108.420 280.343
202003 229.002 108.902 277.104
202006 220.716 108.767 267.407
202009 241.300 109.815 289.556
202012 253.947 109.897 304.505
202103 237.099 111.754 279.577
202106 255.637 114.631 293.871
202109 279.440 115.734 318.173
202112 282.376 117.630 316.336
202203 272.273 121.301 295.786
202206 283.674 125.017 299.012
202209 291.387 125.227 306.627
202212 304.598 125.222 320.541
202303 310.675 127.348 321.478
202306 327.570 128.729 335.325
202309 338.886 129.860 343.888
202312 357.976 129.419 364.495
202403 340.070 131.776 340.070

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Cencora  (LTS:0HF3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=216.74/1034.91
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.39. The lowest was 0.14. And the median was 0.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cencora Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cencora's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora (LTS:0HF3) Business Description

Industry
Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (LTS:0HF3) Headlines

No Headlines